All Comments by

  1. Bart De Strooper on Semagacestat Failure Analysis: Should γ-Secretase Remain a Target?
  2. Yue-Ming Li on Semagacestat Failure Analysis: Should γ-Secretase Remain a Target?
  3. Charles Glabe on Mistakes Prompt Retraction of Controversial Paper, and Publication Ban
  4. Gunnar Gouras on Mistakes Prompt Retraction of Controversial Paper, and Publication Ban
  5. Takaomi Saido on Mistakes Prompt Retraction of Controversial Paper, and Publication Ban
  6. Thomas Bayer and Oliver Wirths on Mistakes Prompt Retraction of Controversial Paper, and Publication Ban
  7. Charles Glabe on Lessons from a failed γ-secretase Alzheimer trial.
  8. Michael Heneka on TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model.
  9. Rebecca Sims on Consortium Debuts Biggest Set of Human Epigenomes To Date
  10. Eric Siemers, Ronald DeMattos, Robert Dean and Karen Sundell on Lessons from a failed γ-secretase Alzheimer trial.
  11. Ammar Al-Chalabi on Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
  12. Nitin Saksena on A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity.
  13. Michael van Es on Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.
  14. Zhigang He on Pathological axonal death through a MAPK cascade that triggers a local energy deficit.
  15. J. de Belleroche on Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.